Wellgistics (WGRX) shares surged after announcing a partnership with Datavault (DVLT) for a blockchain-based initiative called PharmacyChain. This move aims to digitize prescription tracking for improved efficiency and transparency. Despite the spike, WGRX shares are still down significantly from their recent high. Investors see potential for WGRX to evolve into a health-tech innovator, but caution is advised due to the lack of fundamentals and profitability. The initiative is still in its early stages, and WGRX stock remains a risky investment, especially without Wall Street analyst coverage.

Read more at Barchart: This Penny Stock Just Tripled on Blockchain News. Should You Buy Shares Now?